Lista de obras -

A pegylated derivative of alpha-galactosylceramide exhibits improved biological properties

artículo científico publicado en 2007

Bis-(3',5')-cyclic dimeric adenosine monophosphate: strong Th1/Th2/Th17 promoting mucosal adjuvant

artículo científico publicado en 2011

Bivalent mucosal peptide vaccines administered using the LCP carrier system stimulate protective immune responses against Streptococcus pyogenes infection.

artículo científico publicado en 2017

Development and characterization of attenuated metabolic mutants of Bordetella bronchiseptica for applications in vaccinology.

artículo científico publicado en 2012

Efficient nanoparticle-mediated needle-free transcutaneous vaccination via hair follicles requires adjuvantation

artículo científico publicado en 2014

Engineered trivalent immunogen adjuvanted with a STING agonist confers protection against Trypanosoma cruzi infection

artículo científico publicado en 2017

Immunization with Tc52 or its amino terminal domain adjuvanted with c-di-AMP induces Th17+Th1 specific immune responses and confers protection against Trypanosoma cruzi

artículo científico publicado en 2017

Intranasal delivery of influenza rNP adjuvanted with c-di-AMP induces strong humoral and cellular immune responses and provides protection against virus challenge

artículo científico publicado en 2014

Intranasal vaccination with SfbI or M protein-derived peptides conjugated to diphtheria toxoid confers protective immunity against a lethal challenge with Streptococcus pyogenes

artículo científico publicado en 2006

Intranasal vaccination with an adjuvanted polyphosphazenes nanoparticle-based vaccine formulation stimulates protective immune responses in mice

artículo científico publicado en 2017

Inverse micellar sugar glass (IMSG) nanoparticles for transfollicular vaccination

artículo científico publicado en 2015

Modeling Influenza Virus Infection: A Roadmap for Influenza Research

artículo científico publicado en 2015

Mucosal Administration of Cycle-Di-Nucleotide-Adjuvanted Virosomes Efficiently Induces Protection against Influenza H5N1 in Mice

artículo científico publicado en 2017

Mucosal CD8+ T cell responses induced by an MCMV based vaccine vector confer protection against influenza challenge

scientific article published on 16 September 2019

Mucosal Heterologous Prime/Boost Vaccination Induces Polyfunctional Systemic Immunity, Improving Protection Against Trypanosoma cruzi

artículo científico publicado en 2020

Neutral Lipopolyplexes for In Vivo Delivery of Conventional and Replicative RNA Vaccine

scientific article published on 30 July 2019

New Horizons in the Development of Novel Needle-Free Immunization Strategies to Increase Vaccination Efficacy

artículo científico publicado en 2016

Non-invasive delivery of nanoparticles to hair follicles: a perspective for transcutaneous immunization

artículo científico publicado en 2013

Polyethylenimine-based polyplex delivery of self-replicating RNA vaccines.

artículo científico publicado en 2015

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

scientific article published on 19 June 2018

Role of Autophagy in Von Willebrand Factor Secretion by Endothelial Cells and in the In Vivo Thrombin-Antithrombin Complex Formation Promoted by the HIV-1 Matrix Protein p17

artículo científico publicado en 2020

Self-Amplifying Replicon RNA Delivery to Dendritic Cells by Cationic Lipids

artículo científico publicado en 2018

Self-replicating RNA vaccine functionality modulated by fine-tuning of polyplex delivery vehicle structure.

artículo científico publicado en 2017

The Combination Vaccine Adjuvant System Alum/c-di-AMP Results in Quantitative and Qualitative Enhanced Immune Responses Post Immunization

article

The STING activator c-di-AMP exerts superior adjuvant properties than the formulation poly(I:C)/CpG after subcutaneous vaccination with soluble protein antigen or DEC-205-mediated antigen targeting to dendritic cells

artículo científico publicado en 2019

The bacterial second messenger cdiGMP exhibits promising activity as a mucosal adjuvant

artículo científico publicado en 2007

The bacterial second messenger cyclic diGMP exhibits potent adjuvant properties

artículo científico publicado en 2006

The member of the cyclic di-nucleotide family bis-(3', 5')-cyclic dimeric inosine monophosphate exerts potent activity as mucosal adjuvant

artículo científico publicado en 2010

The missing link: Bordetella petrii is endowed with both the metabolic versatility of environmental bacteria and virulence traits of pathogenic Bordetellae

artículo científico publicado en 2008

Type I IFN and not TNF, is Essential for Cyclic Di-nucleotide-elicited CTL by a Cytosolic Cross-presentation Pathway

artículo científico publicado en 2017

Vaccine adjuvants: key tools for innovative vaccine design

artículo científico publicado en 2013

Lista de obras de

A pegylated derivative of alpha-galactosylceramide exhibits improved biological properties

Bis-(3',5')-cyclic dimeric adenosine monophosphate: strong Th1/Th2/Th17 promoting mucosal adjuvant

Bivalent mucosal peptide vaccines administered using the LCP carrier system stimulate protective immune responses against Streptococcus pyogenes infection.

Development and characterization of attenuated metabolic mutants of Bordetella bronchiseptica for applications in vaccinology.

Efficient nanoparticle-mediated needle-free transcutaneous vaccination via hair follicles requires adjuvantation

Engineered trivalent immunogen adjuvanted with a STING agonist confers protection against Trypanosoma cruzi infection

Immunization with Tc52 or its amino terminal domain adjuvanted with c-di-AMP induces Th17+Th1 specific immune responses and confers protection against Trypanosoma cruzi

Intranasal delivery of influenza rNP adjuvanted with c-di-AMP induces strong humoral and cellular immune responses and provides protection against virus challenge

Intranasal vaccination with SfbI or M protein-derived peptides conjugated to diphtheria toxoid confers protective immunity against a lethal challenge with Streptococcus pyogenes

Intranasal vaccination with an adjuvanted polyphosphazenes nanoparticle-based vaccine formulation stimulates protective immune responses in mice

Inverse micellar sugar glass (IMSG) nanoparticles for transfollicular vaccination

Modeling Influenza Virus Infection: A Roadmap for Influenza Research

Mucosal Administration of Cycle-Di-Nucleotide-Adjuvanted Virosomes Efficiently Induces Protection against Influenza H5N1 in Mice

Mucosal CD8+ T cell responses induced by an MCMV based vaccine vector confer protection against influenza challenge

Mucosal Heterologous Prime/Boost Vaccination Induces Polyfunctional Systemic Immunity, Improving Protection Against Trypanosoma cruzi

Neutral Lipopolyplexes for In Vivo Delivery of Conventional and Replicative RNA Vaccine

New Horizons in the Development of Novel Needle-Free Immunization Strategies to Increase Vaccination Efficacy

Non-invasive delivery of nanoparticles to hair follicles: a perspective for transcutaneous immunization

Polyethylenimine-based polyplex delivery of self-replicating RNA vaccines.

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Role of Autophagy in Von Willebrand Factor Secretion by Endothelial Cells and in the In Vivo Thrombin-Antithrombin Complex Formation Promoted by the HIV-1 Matrix Protein p17

Self-Amplifying Replicon RNA Delivery to Dendritic Cells by Cationic Lipids

Self-replicating RNA vaccine functionality modulated by fine-tuning of polyplex delivery vehicle structure.

The Combination Vaccine Adjuvant System Alum/c-di-AMP Results in Quantitative and Qualitative Enhanced Immune Responses Post Immunization

The STING activator c-di-AMP exerts superior adjuvant properties than the formulation poly(I:C)/CpG after subcutaneous vaccination with soluble protein antigen or DEC-205-mediated antigen targeting to dendritic cells

The bacterial second messenger cdiGMP exhibits promising activity as a mucosal adjuvant

The bacterial second messenger cyclic diGMP exhibits potent adjuvant properties

The member of the cyclic di-nucleotide family bis-(3', 5')-cyclic dimeric inosine monophosphate exerts potent activity as mucosal adjuvant

The missing link: Bordetella petrii is endowed with both the metabolic versatility of environmental bacteria and virulence traits of pathogenic Bordetellae

Type I IFN and not TNF, is Essential for Cyclic Di-nucleotide-elicited CTL by a Cytosolic Cross-presentation Pathway

Vaccine adjuvants: key tools for innovative vaccine design